Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells

NCT02881970 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Neonatal Hypoxic-ischaemic Encephalopathy

Interventions

DRUG: autologous cord blood stem cell

Sponsor

Assistance Publique Hopitaux De Marseille